Setbacks for Kidney and Gout Drugs Contribute to Allena Bankruptcy -- Market Talk

Dow Jones

2022/09/06

1055 ET - Publicly traded Allena Pharmaceuticals says it filed for chapter 11 bankruptcy after it experienced setbacks in clinical trials for medications used to treat kidney stones and gout. Programs for both drugs, Reloxaliase and ALLN-346, have been suspended but could potentially be restarted by a buyer of the company's assets or with additional investment in the business, Chief Restructuring Officer Matthew Foster said in a sworn declaration. The Massachusetts-based company filed for bankruptcy Friday in the US Bankruptcy Court in Wilmington, Del., listing total assets of $14.4M and contractual and trade debts of $3.4M. (becky.yerak@wsj.com; @beckyyerak)

$(END)$ Dow Jones Newswires

September 06, 2022 10:55 ET (14:55 GMT)

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2265918700"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2265918700\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2265918700?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-09-06 22:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2265918700","market":"us","top_or_hot":-1,"title":"Setbacks for Kidney and Gout Drugs Contribute to Allena Bankruptcy -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1055 ET - Publicly traded Allena Pharmaceuticals says it filed for chapter 11 bankruptcy after it experienced setbacks in clinical trials for medications used to treat kidney stones and gout. Programs for both drugs, Reloxaliase and ALLN-346, have been suspended but could potentially be restarted by a buyer of the company's assets or with additional investment in the business, Chief Restructuring Officer Matthew Foster said in a sworn declaration. The Massachusetts-based company filed for bankruptcy Friday in the US Bankruptcy Court in Wilmington, Del., listing total assets of $14.4M and contractual and trade debts of $3.4M. (becky.yerak@wsj.com; @beckyyerak) \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  September 06, 2022 10:55 ET (14:55 GMT)\n</p>\n<p>\n  Copyright (c) 2022 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Setbacks for Kidney and Gout Drugs Contribute to Allena Bankruptcy -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSetbacks for Kidney and Gout Drugs Contribute to Allena Bankruptcy -- Market Talk\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2022-09-06 22:55</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1055 ET - Publicly traded Allena Pharmaceuticals says it filed for chapter 11 bankruptcy after it experienced setbacks in clinical trials for medications used to treat kidney stones and gout. Programs for both drugs, Reloxaliase and ALLN-346, have been suspended but could potentially be restarted by a buyer of the company's assets or with additional investment in the business, Chief Restructuring Officer Matthew Foster said in a sworn declaration. The Massachusetts-based company filed for bankruptcy Friday in the US Bankruptcy Court in Wilmington, Del., listing total assets of $14.4M and contractual and trade debts of $3.4M. (becky.yerak@wsj.com; @beckyyerak) \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  September 06, 2022 10:55 ET (14:55 GMT)\n</p>\n<p>\n  Copyright (c) 2022 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2265918700","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2265918700","pubTimestamp":1662476100,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"1055 ET - Publicly traded Allena Pharmaceuticals says it filed for chapter 11 bankruptcy after it ex","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","ALNA":"Allena Pharmaceuticals Inc."},"translate_title":"肾脏和痛风药物的挫折导致Allena破产--市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"END":1,"ALNA":0.9},"content_text":"1055 ET - Publicly traded Allena Pharmaceuticals says it filed for chapter 11 bankruptcy after it experienced setbacks in clinical trials for medications used to treat kidney stones and gout. Programs for both drugs, Reloxaliase and ALLN-346, have been suspended but could potentially be restarted by a buyer of the company's assets or with additional investment in the business, Chief Restructuring Officer Matthew Foster said in a sworn declaration. The Massachusetts-based company filed for bankruptcy Friday in the US Bankruptcy Court in Wilmington, Del., listing total assets of $14.4M and contractual and trade debts of $3.4M. (becky.yerak@wsj.com; @beckyyerak) \n\n\n \n\n\n$(END)$ Dow Jones Newswires\n\n\n  September 06, 2022 10:55 ET (14:55 GMT)\n\n\n  Copyright (c) 2022 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}